Strides Pharma Science Limited: The drug firm said on Saturday that its formulation facility in Bengaluru was inspected by the US health regulator, USFDA. The inspection was completed successfully with a Voluntary Action Indicated (VAI) classification, said the company. The inspection ended on May 24, 2019. As per USFDA, VAI means that though "objectionable practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.